公司資料
Omnicell 股價、新聞與催化劑
- 股票代碼:
- OMCL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
33.60 USD (+0.48%)
收盤價
最後更新: 2026年10月2日
1.91B USD
市值
股價為何變動
截至 2026年10月2日，OMCL 上漲 0.48%，收於 $33.60。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Medication Management Technology Company
Omnicell develops connected devices, software, and services intended to automate medication management across hospitals, health systems, and pharmacies.
Point-of-Care Automation
XT automated dispensing systems and related products control medication storage and access near the patient. The platform supports inventory visibility, security, replenishment, and integration with pharmacy and electronic health-record workflows.
Central Pharmacy Systems
Central pharmacy solutions automate medication packaging, dispensing, inventory handling, and distribution. These systems are designed to reduce manual work and improve the accuracy and traceability of hospital pharmacy operations.
IV Compounding Workflow
IVX and related technologies support sterile compounding through workflow guidance, gravimetric verification, image capture, and documentation. The products address safety and productivity in high-risk intravenous medication preparation.
Software and Technical Services
Omnicell supplements equipment sales with SaaS, analytics, implementation, maintenance, and technical services. Connected data across devices and pharmacy workflows supports its longer-term vision of autonomous medication management.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。